FDA underestimated fetal deaths linked to Bayer's Essure contraceptive: Analyst

Essure--Screenshot courtesy of Bayer

It's more bad news for Bayer in the safety saga over its contraceptive implant, Essure. The FDA in the past has cited 5 fetal deaths linked to the device. But now one analyst is pegging this number much higher. After scouring the agency's side effects reporting database, Madris Tomes, founder and chief executive of data analysis company Device Events, found 303 fetal deaths associated with the product. The news comes as the FDA decides whether to beef up its oversight of Essure after receiving thousands of reports of serious problems from women who used the implant. More from FierceMedicalDevices

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.